{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:46:03Z","timestamp":1791409563440,"version":"4.3.3"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T00:00:00Z","timestamp":1259884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00109-009-0568-7","type":"journal-article","created":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T19:57:34Z","timestamp":1259870254000},"page":"331-338","source":"Crossref","is-referenced-by-count":70,"title":["\u03b2-amyloid oligomers and cellular prion protein in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"88","author":[{"given":"Erik C.","family":"Gunther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Strittmatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"568_CR1","unstructured":"Prince M, Jackson J, Ferri CP, Sousa R, Albanese E, Ribeiro WS, Honyashiki M (2009) Alzheimer\u2019s disease international world alzheimer report 2009. In: International AsD (ed), pp 1\u201396"},{"key":"568_CR2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"A Alzheimer","year":"1995","unstructured":"Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR (1995) An english translation of Alzheimer's 1907 paper, \"Uber eine eigenartige Erkankung der Hirnrinde\". Clin Anat 8:429\u2013431. doi: 10.1002\/ca.980080612","journal-title":"Clin Anat"},{"key":"568_CR3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.genet.32.1.461","volume":"32","author":"DL Price","year":"1998","unstructured":"Price DL, Tanzi RE, Borchelt DR, Sisodia SS (1998) Alzheimer's disease: genetic studies and transgenic models. Annu Rev Genet 32:461\u2013493. doi: 10.1146\/annurev.genet.32.1.461","journal-title":"Annu Rev Genet"},{"key":"568_CR4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","volume":"408","author":"D Morgan","year":"2000","unstructured":"Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982\u2013985. doi: 10.1038\/35050116","journal-title":"Nature"},{"key":"568_CR5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","volume":"408","author":"C Janus","year":"2000","unstructured":"Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D (2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408:979\u2013982. doi: 10.1038\/35050110","journal-title":"Nature"},{"key":"568_CR6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","volume":"372","author":"C Holmes","year":"2008","unstructured":"Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008) Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372:216\u2013223. doi: S0140-6736(08)61075-2 [pii] 10.1016\/S0140-6736(08)61075-2","journal-title":"Lancet"},{"key":"568_CR7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352\u2013357","journal-title":"Nature"},{"key":"568_CR8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837\u2013842. doi: nm1782 [pii] 10.1038\/nm1782","journal-title":"Nat Med"},{"key":"568_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106\u2013113. doi: S0166-4328(08)00083-1 [pii] 10.1016\/j.bbr.2008.02.016","journal-title":"Behav Brain Res"},{"key":"568_CR10","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866\u20132875","journal-title":"J Neurosci"},{"key":"568_CR11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535\u2013539","journal-title":"Nature"},{"key":"568_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","volume":"8","author":"JP Cleary","year":"2005","unstructured":"Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8:79\u201384","journal-title":"Nat Neurosci"},{"key":"568_CR13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796\u2013807","journal-title":"J Neurosci"},{"key":"568_CR14","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","volume":"24","author":"PN Lacor","year":"2004","unstructured":"Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24:10191\u201310200","journal-title":"J Neurosci"},{"key":"568_CR15","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1021\/bi030029q","volume":"42","author":"BA Chromy","year":"2003","unstructured":"Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, Velasco PT, Jones BW, Fernandez SJ, Lacor PN, Horowitz P, Finch CE, Krafft GA, Klein WL (2003) Self-assembly of Abeta(1\u201342) into globular neurotoxins. Biochemistry 42:12749\u201312760","journal-title":"Biochemistry"},{"key":"568_CR16","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1\u201342 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448\u20136453","journal-title":"Proc Natl Acad Sci USA"},{"key":"568_CR17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nchem.247","volume":"1","author":"SL Bernstein","year":"2009","unstructured":"Bernstein SL, Dupuis NF, Lazo ND, Wyttenbach T, Condron MM, Bitan G, Teplow DB, Shea JE, Ruotolo BT, Robinson CV, Bowers MT (2009) Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem 1:326\u2013331. doi: 10.1038\/Nchem.247","journal-title":"Nat Chem"},{"key":"568_CR18","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1021\/ja8092604","volume":"131","author":"MM Murray","year":"2009","unstructured":"Murray MM, Bernstein SL, Nyugen V, Condron MM, Teplow DB, Bowers MT (2009) Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization. J Am Chem Soc 131:6316\u20136317. doi: 10.1021\/ja8092604","journal-title":"J Am Chem Soc"},{"key":"568_CR19","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1074\/jbc.R800036200","volume":"284","author":"R Roychaudhuri","year":"2009","unstructured":"Roychaudhuri R, Yang M, Hoshi MM, Teplow DB (2009) Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem 284:4749\u20134753. doi: R800036200 [pii] 10.1074\/jbc.R800036200","journal-title":"J Biol Chem"},{"key":"568_CR20","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1523\/JNEUROSCI.0395-07.2007","volume":"27","author":"M Knobloch","year":"2007","unstructured":"Knobloch M, Farinelli M, Konietzko U, Nitsch RM, Mansuy IM (2007) Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. J Neurosci 27:7648\u20137653","journal-title":"J Neurosci"},{"key":"568_CR21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","volume":"572","author":"M Townsend","year":"2006","unstructured":"Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ (2006) Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol 572:477\u2013492. doi: jphysiol.2005.103754 [pii] 10.1113\/jphysiol.2005.103754","journal-title":"J Physiol"},{"key":"568_CR22","author":"K Ono","year":"2009","unstructured":"Ono K, Condron MM, Teplow DB (2009) Structure-neurotoxicity relationships of amyloid {beta}-protein oligomers. Proc Natl Acad Sci USA. doi: 0905127106 [pii] 10.1073\/pnas.0905127106","journal-title":"Proc Natl Acad Sci USA"},{"key":"568_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1101\/SQB.1996.061.01.051","volume":"61","author":"C Weissmann","year":"1996","unstructured":"Weissmann C, Fischer M, Raeber A, Bueler H, Sailer A, Shmerling D, Rulicke T, Brandner S, Aguzzi A (1996) The role of PrP in pathogenesis of experimental scrapie. Cold Spring Harb Symp Quant Biol 61:511\u2013522","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"568_CR24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(00)81163-0","volume":"93","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB, Scott MR, DeArmond SJ, Cohen FE (1998) Prion protein biology. Cell 93:337\u2013348. doi: S0092-8674(00)81163-0 [pii]","journal-title":"Cell"},{"key":"568_CR25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519\u2013550. doi: 10.1146\/annurev.neuro.24.1.519 24\/1\/519 [pii]","journal-title":"Annu Rev Neurosci"},{"key":"568_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bmb\/66.1.1","volume":"66","author":"B Chesebro","year":"2003","unstructured":"Chesebro B (2003) Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull 66:1\u201320","journal-title":"Br Med Bull"},{"key":"568_CR27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0092-8674(03)01031-6","volume":"116","author":"A Aguzzi","year":"2004","unstructured":"Aguzzi A, Polymenidou M (2004) Mammalian prion biology: one century of evolving concepts. Cell 116:313\u2013327. doi: S0092867403010316 [pii]","journal-title":"Cell"},{"key":"568_CR28","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","volume":"73","author":"H Bueler","year":"1993","unstructured":"Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339\u20131347. doi: 0092-8674(93)90360-3 [pii]","journal-title":"Cell"},{"key":"568_CR29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/379339a0","volume":"379","author":"S Brandner","year":"1996","unstructured":"Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, Marino S, Weissmann C, Aguzzi A (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339\u2013343. doi: 10.1038\/379339a0","journal-title":"Nature"},{"key":"568_CR30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1090187","volume":"302","author":"G Mallucci","year":"2003","unstructured":"Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871\u2013874. doi: 10.1126\/science.1090187 302\/5646\/871 [pii]","journal-title":"Science"},{"key":"568_CR31","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.1110837","volume":"308","author":"B Chesebro","year":"2005","unstructured":"Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435\u20131439. doi: 308\/5727\/1435 [pii] 10.1126\/science.1110837","journal-title":"Science"},{"key":"568_CR32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7601930","volume":"27","author":"KF Winklhofer","year":"2008","unstructured":"Winklhofer KF, Tatzelt J, Haass C (2008) The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J 27:336\u2013349. doi: 7601930 [pii] 10.1038\/sj.emboj.7601930","journal-title":"EMBO J"},{"key":"568_CR33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-291X(66)90478-5","volume":"22","author":"T Alper","year":"1966","unstructured":"Alper T, Haig DA, Clarke MC (1966) The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 22:278\u2013284. doi: 0006-291X(66)90478-5 [pii]","journal-title":"Biochem Biophys Res Commun"},{"key":"568_CR34","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1073\/pnas.75.12.6268","volume":"75","author":"CJ Gibbs Jr","year":"1978","unstructured":"Gibbs CJ Jr, Gajdusek DC, Latarjet R (1978) Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt\u2013Jakob disease, and scrapie. Proc Natl Acad Sci USA 75:6268\u20136270","journal-title":"Proc Natl Acad Sci USA"},{"key":"568_CR35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0042-6822(88)90569-7","volume":"164","author":"CG Bellinger-Kawahara","year":"1988","unstructured":"Bellinger-Kawahara CG, Kempner E, Groth D, Gabizon R, Prusiner SB (1988) Scrapie prion liposomes and rods exhibit target sizes of 55, 000\u00a0Da. Virology 164:537\u2013541","journal-title":"Virology"},{"key":"568_CR36","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1073\/pnas.84.12.4017","volume":"84","author":"R Gabizon","year":"1987","unstructured":"Gabizon R, McKinley MP, Prusiner SB (1987) Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci USA 84:4017\u20134021","journal-title":"Proc Natl Acad Sci USA"},{"key":"568_CR37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature03989","volume":"437","author":"JR Silveira","year":"2005","unstructured":"Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B (2005) The most infectious prion protein particles. Nature 437:257\u2013261. doi: nature03989 [pii] 10.1038\/nature03989","journal-title":"Nature"},{"key":"568_CR38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112. doi: nrm2101 [pii] 10.1038\/nrm2101","journal-title":"Nat Rev Mol Cell Biol"},{"key":"568_CR39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/22241","volume":"400","author":"C Kuwahara","year":"1999","unstructured":"Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Yokoyama T, Itohara S, Onodera T (1999) Prions prevent neuronal cell-line death. Nature 400:225\u2013226. doi: 10.1038\/22241","journal-title":"Nature"},{"key":"568_CR40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9440(10)63291-9","volume":"165","author":"NF McLennan","year":"2004","unstructured":"McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, Ritchie D, Brannan F, Head MW, Ironside JW, Williams A, Bell JE (2004) Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 165:227\u2013235","journal-title":"Am J Pathol"},{"key":"568_CR41","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1523\/JNEUROSCI.1115-05.2005","volume":"25","author":"WC Shyu","year":"2005","unstructured":"Shyu WC, Lin SZ, Chiang MF, Ding DC, Li KW, Chen SF, Yang HI, Li H (2005) Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci 25:8967\u20138977. doi: 25\/39\/8967 [pii] 10.1523\/JNEUROSCI.1115-05.2005","journal-title":"J Neurosci"},{"key":"568_CR42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.nbd.2005.04.002","volume":"20","author":"A Spudich","year":"2005","unstructured":"Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, Bassetti CL, Hermann DM (2005) Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1\/-2 and STAT-1. Neurobiol Dis 20:442\u2013449. doi: S0969-9961(05)00113-0 [pii] 10.1016\/j.nbd.2005.04.002","journal-title":"Neurobiol Dis"},{"key":"568_CR43","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.STR.0000217262.03192.d4","volume":"37","author":"J Weise","year":"2006","unstructured":"Weise J, Sandau R, Schwarting S, Crome O, Wrede A, Schulz-Schaeffer W, Zerr I, Bahr M (2006) Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 37:1296\u20131300. doi: 01.STR.0000217262.03192.d4 [pii] 10.1161\/01.STR.0000217262.03192.d4","journal-title":"Stroke"},{"key":"568_CR44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1750-3639.2007.00061.x","volume":"17","author":"G Mitteregger","year":"2007","unstructured":"Mitteregger G, Vosko M, Krebs B, Xiang W, Kohlmannsperger V, Nolting S, Hamann GF, Kretzschmar HA (2007) The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol 17:174\u2013183. doi: BPA061 [pii] 10.1111\/j.1750-3639.2007.00061.x","journal-title":"Brain Pathol"},{"key":"568_CR45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbadis.2007.02.011","volume":"1772","author":"L Westergard","year":"2007","unstructured":"Westergard L, Christensen HM, Harris DA (2007) The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 1772:629\u2013644. doi: S0925-4439(07)00060-9 [pii] 10.1016\/j.bbadis.2007.02.011","journal-title":"Biochim Biophys Acta"},{"key":"568_CR46","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1074\/jbc.270.7.3299","volume":"270","author":"SA Priola","year":"1995","unstructured":"Priola SA, Caughey B, Wehrly K, Chesebro B (1995) A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. J Biol Chem 270:3299\u20133305","journal-title":"J Biol Chem"},{"key":"568_CR47","doi-asserted-by":"crossref","first-page":"38081","DOI":"10.1074\/jbc.M007114200","volume":"275","author":"RK Meyer","year":"2000","unstructured":"Meyer RK, Lustig A, Oesch B, Fatzer R, Zurbriggen A, Vandevelde M (2000) A monomer-dimer equilibrium of a cellular prion protein (PrPC) not observed with recombinant PrP. J Biol Chem 275:38081\u201338087. doi: 10.1074\/jbc.M007114200 M007114200 [pii]","journal-title":"J Biol Chem"},{"key":"568_CR48","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1126\/science.289.5486.1925","volume":"289","author":"S Mouillet-Richard","year":"2000","unstructured":"Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O (2000) Signal transduction through prion protein. Science 289:1925\u20131928. doi: 8827 [pii]","journal-title":"Science"},{"key":"568_CR49","doi-asserted-by":"crossref","first-page":"13326","DOI":"10.1073\/pnas.2235648100","volume":"100","author":"B Schneider","year":"2003","unstructured":"Schneider B, Mutel V, Pietri M, Ermonval M, Mouillet-Richard S, Kellermann O (2003) NADPH oxidase and extracellular regulated kinases 1\/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 100:13326\u201313331. doi: 10.1073\/pnas.2235648100 2235648100 [pii]","journal-title":"Proc Natl Acad Sci USA"},{"key":"568_CR50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0092-8674(00)81572-X","volume":"93","author":"D Shmerling","year":"1998","unstructured":"Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J, Rulicke T, Flechsig E, Cozzio A, von Mering C, Hangartner C, Aguzzi A, Weissmann C (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93:203\u2013214. doi: S0092-8674(00)81572-X [pii]","journal-title":"Cell"},{"key":"568_CR51","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.emboj.7601510","volume":"26","author":"F Baumann","year":"2007","unstructured":"Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, Heikenwalder M, Rulicke T, Burkle A, Aguzzi A (2007) Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 26:538\u2013547. doi: 7601510 [pii] 10.1038\/sj.emboj.7601510","journal-title":"EMBO J"},{"key":"568_CR52","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.emboj.7601507","volume":"26","author":"A Li","year":"2007","unstructured":"Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, Harris DA (2007) Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105\u2013125. EMBO J 26:548\u2013558. doi: 7601507 [pii] 10.1038\/sj.emboj.7601507","journal-title":"EMBO J"},{"key":"568_CR53","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1006\/bbrc.2000.3829","volume":"278","author":"J Warwicker","year":"2000","unstructured":"Warwicker J (2000) Modeling a prion protein dimer: predictions for fibril formation. Biochem Biophys Res Commun 278:646\u2013652. doi: 10.1006\/bbrc.2000.3829 S0006-291X(00)93829-4 [pii]","journal-title":"Biochem Biophys Res Commun"},{"key":"568_CR54","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/emboj.2008.122","volume":"27","author":"AS Rambold","year":"2008","unstructured":"Rambold AS, Muller V, Ron U, Ben-Tal N, Winklhofer KF, Tatzelt J (2008) Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J 27:1974\u20131984. doi: emboj2008122 [pii] 10.1038\/emboj.2008.122","journal-title":"EMBO J"},{"key":"568_CR55","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.neurobiolaging.2007.04.026","volume":"29","author":"G Giaccone","year":"2008","unstructured":"Giaccone G, Mangieri M, Capobianco R, Limido L, Hauw JJ, Haik S, Fociani P, Bugiani O, Tagliavini F (2008) Tauopathy in human and experimental variant Creutzfeldt\u2013Jakob disease. Neurobiol Aging 29:1864\u20131873. doi: S0197-4580(07)00198-4 [pii] 10.1016\/j.neurobiolaging.2007.04.026","journal-title":"Neurobiol Aging"},{"key":"568_CR56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.1995.tb00578.x","volume":"5","author":"B Ghetti","year":"1995","unstructured":"Ghetti B, Dlouhy SR, Giaccone G, Bugiani O, Frangione B, Farlow MR, Tagliavini F (1995) Gerstmann\u2013Straussler\u2013Scheinker disease and the Indiana kindred. Brain Pathol 5:61\u201375","journal-title":"Brain Pathol"},{"key":"568_CR57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02778006","volume":"8","author":"B Ghetti","year":"1994","unstructured":"Ghetti B, Tagliavini F, Giaccone G, Bugiani O, Frangione B, Farlow MR, Dlouhy SR (1994) Familial Gerstmann\u2013Straussler\u2013Scheinker disease with neurofibrillary tangles. Mol Neurobiol 8:41\u201348. doi: 10.1007\/BF02778006","journal-title":"Mol Neurobiol"},{"key":"568_CR58","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.39.11.1453","volume":"39","author":"B Ghetti","year":"1989","unstructured":"Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L, Farlow MR, Conneally PM, Dlouhy SR, Azzarelli B et al (1989) Gerstmann\u2013Straussler\u2013Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39:1453\u20131461","journal-title":"Neurology"},{"key":"568_CR59","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10571-007-9224-3","volume":"27","author":"JP Lopes","year":"2007","unstructured":"Lopes JP, Oliveira CR, Agostinho P (2007) Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-beta and Prion peptides: implications for Alzheimer's disease and Prion-related encephalopathies. Cell Mol Neurobiol 27:943\u2013957. doi: 10.1007\/s10571-007-9224-3","journal-title":"Cell Mol Neurobiol"},{"key":"568_CR60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(01)02264-9","volume":"313","author":"B Everbroeck Van","year":"2001","unstructured":"Van Everbroeck B, Croes EA, Pals P, Dermaut B, Jansen G, van Duijn CM, Cruts M, Van Broeckhoven C, Martin JJ, Cras P (2001) Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt\u2013Jakob disease phenotype. Neurosci Lett 313:69\u201372","journal-title":"Neurosci Lett"},{"key":"568_CR61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12031-007-9001-2","volume":"34","author":"A Krasnianski","year":"2008","unstructured":"Krasnianski A, von Ahsen N, Heinemann U, Meissner B, Kretzschmar HA, Armstrong VW, Zerr I (2008) ApoE distribution and family history in genetic prion diseases in Germany. J Mol Neurosci 34:45\u201350. doi: 10.1007\/s12031-007-9001-2","journal-title":"J Mol Neurosci"},{"key":"568_CR62","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/brain\/awn202","volume":"131","author":"TE Webb","year":"2008","unstructured":"Webb TE, Poulter M, Beck J, Uphill J, Adamson G, Campbell T, Linehan J, Powell C, Brandner S, Pal S, Siddique D, Wadsworth JD, Joiner S, Alner K, Petersen C, Hampson S, Rhymes C, Treacy C, Storey E, Geschwind MD, Nemeth AH, Wroe S, Collinge J, Mead S (2008) Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 131:2632\u20132646. doi: awn202 [pii] 10.1093\/brain\/awn202","journal-title":"Brain"},{"key":"568_CR63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3940(95)11353-3","volume":"187","author":"SM Pickering-Brown","year":"1995","unstructured":"Pickering-Brown SM, Mann DM, Owen F, Ironside JW, de Silva R, Roberts DA, Balderson DJ, Cooper PN (1995) Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt\u2013Jakob disease. Neurosci Lett 187:127\u2013129. doi: 0304-3940(95)11353-3 [pii]","journal-title":"Neurosci Lett"},{"key":"568_CR64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt\u2013Jakob disease. Brain Res 541:163\u2013166. doi: 0006-8993(91)91092-F [pii]","journal-title":"Brain Res"},{"key":"568_CR65","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1002\/pmic.200900085","volume":"9","author":"A Giorgi","year":"2009","unstructured":"Giorgi A, Di Francesco L, Principe S, Mignogna G, Sennels L, Mancone C, Alonzi T, Sbriccoli M, De Pascalis A, Rappsilber J, Cardone F, Pocchiari M, Maras B, Schinina ME (2009) Proteomic profiling of PrP27\u201330-enriched preparations extracted from the brain of hamsters with experimental scrapie. Proteomics 9:3802\u20133814. doi: 10.1002\/pmic.200900085","journal-title":"Proteomics"},{"key":"568_CR66","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.0609621104","volume":"104","author":"ET Parkin","year":"2007","unstructured":"Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, Baybutt HN, Turner AJ, Hooper NM (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci USA 104:11062\u201311067. doi: 0609621104 [pii] 10.1073\/pnas.0609621104","journal-title":"Proc Natl Acad Sci USA"},{"key":"568_CR67","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nbt969","volume":"22","author":"G Schmitt-Ulms","year":"2004","unstructured":"Schmitt-Ulms G, Hansen K, Liu J, Cowdrey C, Yang J, DeArmond SJ, Cohen FE, Prusiner SB, Baldwin MA (2004) Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat Biotechnol 22:724\u2013731. doi: 10.1038\/nbt969 nbt969 [pii]","journal-title":"Nat Biotechnol"},{"key":"568_CR68","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781\u20131784. doi: 313\/5794\/1781 [pii] 10.1126\/science.1131864","journal-title":"Science"},{"key":"568_CR69","doi-asserted-by":"crossref","first-page":"12926","DOI":"10.1073\/pnas.0903200106","volume":"106","author":"YS Eisele","year":"2009","unstructured":"Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX, Roth K, Aguzzi A, Staufenbiel M, Walker LC, Jucker M (2009) Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci USA 106:12926\u201312931. doi: 0903200106 [pii] 10.1073\/pnas.0903200106","journal-title":"Proc Natl Acad Sci USA"},{"key":"568_CR70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ana.10507","volume":"53","author":"B Dermaut","year":"2003","unstructured":"Dermaut B, Croes EA, Rademakers R, Van den Broeck M, Cruts M, Hofman A, van Duijn CM, Van Broeckhoven C (2003) PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease. Ann Neurol 53:409\u2013412. doi: 10.1002\/ana.10507","journal-title":"Ann Neurol"},{"key":"568_CR71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.WNL.0000130198.72589.69","volume":"63","author":"M Riemenschneider","year":"2004","unstructured":"Riemenschneider M, Klopp N, Xiang W, Wagenpfeil S, Vollmert C, Muller U, Forstl H, Illig T, Kretzschmar H, Kurz A (2004) Prion protein codon 129 polymorphism and risk of Alzheimer disease. Neurology 63:364\u2013366. doi: 63\/2\/364 [pii]","journal-title":"Neurology"},{"key":"568_CR72","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/hmg\/ddi228","volume":"14","author":"A Papassotiropoulos","year":"2005","unstructured":"Papassotiropoulos A, Wollmer MA, Aguzzi A, Hock C, Nitsch RM, de Quervain DJ (2005) The prion gene is associated with human long-term memory. Hum Mol Genet 14:2241\u20132246. doi: ddi228 [pii] 10.1093\/hmg\/ddi228","journal-title":"Hum Mol Genet"},{"key":"568_CR73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ana.10658","volume":"54","author":"EA Croes","year":"2003","unstructured":"Croes EA, Dermaut B, Houwing-Duistermaat JJ, Van den Broeck M, Cruts M, Breteler MM, Hofman A, van Broeckhoven C, van Duijn CM (2003) Early cognitive decline is associated with prion protein codon 129 polymorphism. Ann Neurol 54:275\u2013276. doi: 10.1002\/ana.10658","journal-title":"Ann Neurol"},{"key":"568_CR74","first-page":"45","volume":"65","author":"H Li","year":"2008","unstructured":"Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, Fornazzari L, Gauthier S, Goodgame N, Guzman D, Hammond S, Hollingworth P, Hsiung GY, Johnson J, Kelly DD, Keren R, Kertesz A, King KS, Lovestone S, Loy-English I, Matthews PM, Owen MJ, Plumpton M, Pryse-Phillips W, Prinjha RK, Richardson JC, Saunders A, Slater AJ, St George-Hyslop PH, Stinnett SW, Swartz JE, Taylor RL, Wherrett J, Williams J, Yarnall DP, Gibson RA, Irizarry MC, Middleton LT, Roses AD (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65:45\u201353. doi: 2007.3 [pii] 10.1001\/archneurol.2007.3","journal-title":"Arch Neurol"},{"key":"568_CR75","doi-asserted-by":"crossref","unstructured":"Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-[bgr] oligomers. Nature 457: 1128-1132. DOI http:\/\/www.nature.com\/nature\/journal\/v457\/n7233\/suppinfo\/nature07761_S1.html","DOI":"10.1038\/nature07761"},{"key":"568_CR76","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1126\/science.1094273","volume":"303","author":"L Solforosi","year":"2004","unstructured":"Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, Sugama S, DeGiorgio LA, Volpe BT, Wiseman E, Abalos G, Masliah E, Gilden D, Oldstone MB, Conti B, Williamson RA (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303:1514\u20131516. doi: 10.1126\/science.1094273 1094273 [pii]","journal-title":"Science"},{"key":"568_CR77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000121389","volume":"5","author":"L Debatin","year":"2008","unstructured":"Debatin L, Streffer J, Geissen M, Matschke J, Aguzzi A, Glatzel M (2008) Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt\u2013Jakob disease. Neurodegene Dis 5:347\u2013354. doi: 000121389 [pii] 10.1159\/000121389","journal-title":"Neurodegene Dis"},{"key":"568_CR78","author":"F Meyne","year":"2009","unstructured":"Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, Zerr I (2009) Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis. doi: 12G39G6736J3K264 [pii] 10.3233\/JAD-2009-1110","journal-title":"J Alzheimers Dis"},{"key":"568_CR79","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1016\/j.jbiomech.2007.03.023","volume":"40","author":"T Oda","year":"2007","unstructured":"Oda T, Himeno R, CH D, Chino K, Kurihara T, Nagayoshi T, Kanehisa H, Fukunaga T, Kawakami Y (2007) In vivo behavior of muscle fascicles and tendinous tissues in human tibialis anterior muscle during twitch contraction. J Biomech 40:3114\u20133120. doi: S0021-9290(07)00144-3 [pii] 10.1016\/j.jbiomech.2007.03.023","journal-title":"J Biomech"},{"key":"568_CR80","doi-asserted-by":"crossref","first-page":"13805","DOI":"10.1523\/JNEUROSCI.4218-08.2008","volume":"28","author":"Y Liu","year":"2008","unstructured":"Liu Y, Yoo MJ, Savonenko A, Stirling W, Price DL, Borchelt DR, Mamounas L, Lyons WE, Blue ME, Lee MK (2008) Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J Neurosci 28:13805\u201313814. doi: 28\/51\/13805 [pii] 10.1523\/JNEUROSCI.4218-08.2008","journal-title":"J Neurosci"},{"key":"568_CR81","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1523\/JNEUROSCI.2211-04.2004","volume":"24","author":"TD Stein","year":"2004","unstructured":"Stein TD, Anders NJ, DeCarli C, Chan SL, Mattson MP, Johnson JA (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J Neurosci 24:7707\u20137717. doi: 10.1523\/JNEUROSCI.2211-04.2004 24\/35\/7707 [pii]","journal-title":"J Neurosci"},{"key":"568_CR82","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature07767","volume":"457","author":"A Nikolaev","year":"2009","unstructured":"Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981\u2013989. doi: nature07767 [pii] 10.1038\/nature07767","journal-title":"Nature"},{"key":"568_CR83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13:159\u2013170","journal-title":"Hum Mol Genet"},{"key":"568_CR84","doi-asserted-by":"crossref","unstructured":"Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-\u03b2 oligomers. Nature 457:1128\u20131132. doi: 10.1038\/nature07761","DOI":"10.1038\/nature07761"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-009-0568-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-009-0568-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-009-0568-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T06:37:55Z","timestamp":1558679875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-009-0568-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,4]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1007\/s00109-009-0568-7","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,4]]}}}